Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

Imagem de Miniatura
Arquivos
art_STANAWAY_Global_regional_and_national_comparative_risk_assessment_of_2018.PDF (9.57 MB)
Citações na Scopus
3245
Tipo de produção
article
Data de publicação
2018
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
STANAWAY, Jeffrey D.
AFSHIN, Ashkan
GAKIDOU, Emmanuela
LIM, Stephen S.
ABATE, Degu
ABATE, Kalkidan Hassell
ABBAFATI, Cristiana
ABBASI, Nooshin
ABBASTABAR, Hedayat
ABD-ALLAH, Foad
Citação
LANCET, v.392, n.10159, p.1923-1994, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk outcome associations. With each annual GBD study, we update the GBD CRA to incorporate improved methods, new risks and risk outcome pairs, and new data on risk exposure levels and risk outcome associations. Methods We used the CRA framework developed for previous iterations of GBD to estimate levels and trends in exposure, attributable deaths, and attributable disability-adjusted life-years (DALYs), by age group, sex, year, and location for 84 behavioural, environmental and occupational, and metabolic risks or groups of risks from 1990 to 2017. This study included 476 risk outcome pairs that met the GBD study criteria for convincing or probable evidence of causation. We extracted relative risk and exposure estimates from 46 749 randomised controlled trials, cohort studies, household surveys, census data, satellite data, and other sources. We used statistical models to pool data, adjust for bias, and incorporate covariates. Using the counterfactual scenario of theoretical minimum risk exposure level (TMREL), we estimated the portion of deaths and DALYs that could be attributed to a given risk. We explored the relationship between development and risk exposure by modelling the relationship between the Socio-demographic Index (SDI) and risk-weighted exposure prevalence and estimated expected levels of exposure and risk-attributable burden by SDI. Finally, we explored temporal changes in risk-attributable DALYs by decomposing those changes into six main component drivers of change as follows: (1) population growth; (2) changes in population age structures; (3) changes in exposure to environmental and occupational risks; (4) changes in exposure to behavioural risks; (5) changes in exposure to metabolic risks; and (6) changes due to all other factors, approximated as the risk-deleted death and DALY rates, where the risk-deleted rate is the rate that would be observed had we reduced the exposure levels to the TMREL for all risk factors included in GBD 2017. Findings In 2017,34.1 million (95% uncertainty interval [UI] 33.3-35.0) deaths and 121 billion (144-1.28) DALYs were attributable to GBD risk factors. Globally, 61.0% (59.6-62.4) of deaths and 48.3% (46.3-50.2) of DALYs were attributed to the GBD 2017 risk factors. When ranked by risk-attributable DALYs, high systolic blood pressure (SBP) was the leading risk factor, accounting for 10.4 million (9.39-11.5) deaths and 218 million (198-237) DALYs, followed by smoking (7.10 million [6.83-7.37] deaths and 182 million [173-193] DALYs), high fasting plasma glucose (6.53 million [5.23-8.23] deaths and 171 million [144-201] DALYs), high body-mass index (BMI; 4.72 million [2.99-6.70] deaths and 148 million [98.6-202] DALYs), and short gestation for birthweight (1.43 million [1.36-1.51] deaths and 139 million [131-147] DALYs). In total, risk-attributable DALYs declined by 4.9% (3.3-6.5) between 2007 and 2017. In the absence of demographic changes (ie, population growth and ageing), changes in risk exposure and risk-deleted DALYs would have led to a 23.5% decline in DALYs during that period. Conversely, in the absence of changes in risk exposure and risk-deleted DALYs, demographic changes would have led to an 18.6% increase in DALYs during that period. The ratios of observed risk exposure levels to exposure levels expected based on SDI (O/E ratios) increased globally for unsafe drinking water and household air pollution between 1990 and 2017. This result suggests that development is occurring more rapidly than are changes in the underlying risk structure in a population. Conversely, nearly universal declines in O/E ratios for smoking and alcohol use indicate that, for a given SDI, exposure to these risks is declining. In 2017, the leading Level 4 risk factor for age-standardised DALY rates was high SBP in four super-regions: central Europe, eastern Europe, and central Asia; north Africa and Middle East; south Asia; and southeast Asia, east Asia, and Oceania. The leading risk factor in the high-income super-region was smoking, in Latin America and Caribbean was high BMI, and in sub-Saharan Africa was unsafe sex. O/E ratios for unsafe sex in sub-Saharan Africa were notably high, and those for alcohol use in north Africa and the Middle East were notably low. Interpretation By quantifying levels and trends in exposures to risk factors and the resulting disease burden, this assessment offers insight into where past policy and programme efforts might have been successful and highlights current priorities for public health action. Decreases in behavioural, environmental, and occupational risks have largely offset the effects of population growth and ageing, in relation to trends in absolute burden. Conversely, the combination of increasing metabolic risks and population ageing will probably continue to drive the increasing trends in non-communicable diseases at the global level, which presents both a public health challenge and opportunity. We see considerable spatiotemporal heterogeneity in levels of risk exposure and risk-attributable burden. Although levels of development underlie some of this heterogeneity, O/E ratios show risks for which countries are overperforming or underperforming relative to their level of development. As such, these ratios provide a benchmarking tool to help to focus local decision making. Our findings reinforce the importance of both risk exposure monitoring and epidemiological research to assess causal connections between risks and health outcomes, and they highlight the usefulness of the GBD study in synthesising data to draw comprehensive and robust conclusions that help to inform good policy and strategic health planning.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/31630
Referências
  1. Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1
  2. American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P
  3. [Anonymous], 2017, WHO REP GLOB TOB EP
  4. Bilano V, 2015, LANCET, V385, P966, DOI 10.1016/S0140-6736(15)60264-1
  5. Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4
  6. Chaloupka FJ, 2012, TOB CONTROL, V21, P172, DOI 10.1136/tobaccocontrol-2011-050417
  7. Das Gupta P., 1993, STANDARDIZATION DECO
  8. Farvid MS, 2014, CIRCULATION, V130, P1568, DOI 10.1161/CIRCULATIONAHA.114.010236
  9. Fewtrell LJ, 2004, ENVIRON RES, V94, P120, DOI 10.1016/S0013-9351(03)00132-4
  10. Frieden TR, 2018, LANCET, V391, P709, DOI 10.1016/S0140-6736(17)32443-1
  11. FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  12. Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8
  13. Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0
  14. Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X
  15. Health Effects Institute, 2018, SPEC REP GLOB EXP AI
  16. Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765
  17. Kyu HH, 2018, LANCET, V392, P1859, DOI 10.1016/s0140-6736(18)32335-3
  18. Menesini E, 2017, PSYCHOL HEALTH MED, V22, P240, DOI 10.1080/13548506.2017.1279740
  19. Moore SE, 2017, WORLD J PSYCHIATR, V7, P60, DOI 10.5498/wjp.v7.i1.60
  20. Murray CJL, 1999, EPIDEMIOLOGY, V10, P594, DOI 10.1097/00001648-199909000-00029
  21. Murray-Kolb LE, 2012, CHERG IRON REPORT MA
  22. Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9
  23. Petry N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110693
  24. Prabhakaran D, 2018, LANCET, V391, P1224, DOI 10.1016/S0140-6736(17)32471-6
  25. Rajagopalan S, 2012, DIABETES, V61, P3037, DOI 10.2337/db12-0190
  26. Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1
  27. Rushton L, 2012, BRIT J CANCER, V107, pS3, DOI 10.1038/bjc.2012.112
  28. Scott JG, 2014, AUST NZ J PSYCHIAT, V48, P209, DOI 10.1177/0004867413508456
  29. Shaddick G, 2018, J R STAT SOC C-APPL, V67, P231, DOI 10.1111/rssc.12227
  30. Singh GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065174
  31. Singh K, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017809
  32. Steenland K, 2016, OCCUP ENVIRON MED, V73, P497, DOI 10.1136/oemed-2016-103743
  33. Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9
  34. Takala J, 2014, J OCCUP ENVIRON HYG, V11, P326, DOI 10.1080/15459624.2013.863131
  35. Tian MY, 2015, CIRCULATION, V132, P815, DOI 10.1161/CIRCULATIONAHA.115.015373
  36. UNICEF WHO World Bank Group, 2017, JOINT CHILD MALN EST
  37. Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7
  38. Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2
  39. Wardlaw TM, 2004, LOW BIRTHW COUNTR RE
  40. Webster R, 2018, JAMA-J AM MED ASSOC, V320, P566, DOI 10.1001/jama.2018.10359
  41. WHO, GLOBAL REGIONAL ESTI
  42. WHO UNICEF, JOINT MON PROGR METH
  43. World Health Organization (WHO), PROGR DRINK WAT SAN
  44. Yang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021481
  45. Yusuf S, 2016, NEW ENGL J MED, V374, P2021, DOI 10.1056/NEJMoa1600176

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - HU
Artigos e Materiais de Revistas Científicas - LIM/20
Artigos e Materiais de Revistas Científicas - LIM/23
Artigos e Materiais de Revistas Científicas - LIM/51